LIVE

Serial Number

97777942

Owner

Cancervax, Inc.

Attorney

Jeffery M. Lillywhite

First Use Date

Sep 27, 2022

Filing Date

Feb 2, 2023

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

CX Trademark

Serial Number: 97777942 • Registration: 7417642

CX is a trademark filed by Cancervax, Inc. on February 2, 2023. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Trademark Classes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

Cancervax, Inc. (14 trademarks)

802 84th Avenue NE
Medina, WA 98039

Entity Type: 03

Legal Representation

Attorney of Record

Jeffery M. Lillywhite

1,210 trademarks filed View all →

Trademark Details

Filing Date

February 2, 2023

Registration Date

June 18, 2024

First Use Anywhere

September 27, 2022

First Use in Commerce

September 27, 2022

Published for Opposition

April 2, 2024

Goods & Services

Pharmaceutical drug development services; Pharmaceutical research services; Providing information about medical research in the field of cancer, pharmaceutical drugs, cancer risks, and Immunotherapy

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jun 18, 2024 NRCC

REGISTERED-PRINCIPAL REGISTER

Jun 18, 2024 R.PR

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jun 13, 2024 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jun 13, 2024 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jun 13, 2024 REAP

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 2, 2024 NPUB

PUBLISHED FOR OPPOSITION

Apr 2, 2024 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 13, 2024 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Feb 26, 2024 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 7, 2024 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 6, 2024 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 6, 2024 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Nov 13, 2023 GNRN

NON-FINAL ACTION E-MAILED

Nov 13, 2023 GNRT

NON-FINAL ACTION WRITTEN

Nov 13, 2023 CNRT

ASSIGNED TO EXAMINER

Oct 31, 2023 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 21, 2023 NWOS

NEW APPLICATION ENTERED

Feb 7, 2023 NWAP

Related Trademarks

More from this Owner

CX CANCERVAX

CANCERVAX

CX CANCERVAX

CANCERVAX

More in Same Class

CORE BIOGENESIS

STREEM